Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Covid-19 Prevention and Treatment by Targeting Proteins: An Experience to Fight Emerging Diseases Publisher Pubmed



Zare H1 ; Farkhondeh T2 ; Bakherad H3 ; Sharifi H4 ; Shirzeyli MH5 ; Samarghandian S6 ; Ghasemi F7, 8
Authors

Source: Current Molecular Medicine Published:2024


Abstract

The coronavirus disease 2019 (Covid-19) pandemic has been considered a major threat to human health. Effective therapeutic approaches are urgently required. Spike protein and the Angiotensin-converting enzyme 2 (ACE2) receptors have critical roles in SARS-CoV-2 infection. As a result, these two proteins are considered potential targets for the development of a wide variety of biotherapeutics and vaccines for controlling Covid-19. The fusion proteins have desirable medicinal properties, including high serum half-life, stability, and solubility in the body. Moreover, other Fc-fusion proteins used to treat other diseases have no known side effects. These Fc-fusion proteins are valuable biopharmaceuticals and have been proposed as therapeutic candidates for the treatment and prevention of Covid-19 owing to their potential therapeutic benefits. © 2024 Bentham Science Publishers.
Other Related Docs
7. Molecular Aspects of Co-Morbidities in Covid-19 Infection, Archives of Bone and Joint Surgery (2020)
15. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
18. Jak Inhibition As a New Treatment Strategy for Patients With Covid-19, International Archives of Allergy and Immunology (2020)